Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis
Seminars in Thrombosis and Hemostasis · 2024-03 · 50 (02) · 288-294
DOI: 10.1055/s-0043-1769014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 19.05.2023. Verfasst von Simone Turner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: COVID-19, Thrombosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
The prevailing hypotheses for the persistent symptoms of Long COVID have been narrowed down to immune dysregulation and autoantibodies, widespread organ damage, viral persistence, and fibrinaloid microclots (entrapping numerous inflammatory molecules) together with platelet hyperactivation. Here we demonstrate significantly increased concentrations of von Willebrand factor (VWF), platelet factor 4 (PF4), serum amyloid A (SAA), α-2 antiplasmin (α-2AP), endothelial-leukocyte adhesion molecule 1 (E-selectin), and platelet endothelial cell adhesion molecule (PECAM-1) in the soluble part of the blood. It was noteworthy that the mean level of α-2 antiplasmin exceeded the upper limit of the laboratory reference range in Long COVID patients, and the other 5 were significantly elevated in Long COVID patients as compared to the controls. This is alarming if we take into consideration that a significant amount of the total burden of these inflammatory molecules has previously been shown to be entrapped inside fibrinolysis-resistant microclots (thus decreasing the apparent level of the soluble molecules). We conclude that presence of microclotting, together with relatively high levels of six biomarkers known to be key drivers of endothelial and clotting pathology, points to thrombotic endothelialitis as a key pathological process in Long COVID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.
- Mediclinic Stellenbosch, Stellenbosch, South Africa.
- Department of Respiratory Medicine, Wythenshawe Hospital, Manchester University, Manchester, United Kingdom.
- Department of Biochemistry and Systems Biology; Institute of Systems, Molecular and Integrative Biology; Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.
- Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kemitorvet Lyngby, Denmark.
ORCID-Profile: Douglas B Kell, Etheresia Pretorius
Zitieren
APA
Turner, S., Naidoo, C. A., Usher, T. J., Kruger, A., Venter, C., Laubscher, G. J., Khan, M. A., Kell, D. B., & Pretorius, E. (2024). Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis. Seminars in Thrombosis and Hemostasis, 50(02), 288-294. https://doi.org/10.1055/s-0043-1769014
Vancouver
Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ, et al. Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis. Seminars in Thrombosis and Hemostasis. 2024;50(02):288-294. doi:10.1055/s-0043-1769014
BibTeX
@article{Turner2024,
author = {Turner, Simone and Naidoo, Caitlin A and Usher, Thomas J and Kruger, Arneaux and Venter, Chantelle and Laubscher, Gert J and Khan, M Asad and Kell, Douglas B and Pretorius, Etheresia},
title = {Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2024},
volume = {50},
number = {02},
pages = {288--294},
doi = {10.1055/s-0043-1769014}
}
EUVIMED